NGQ1
Medicure Inc
Save
–
Market cap
12.17x
Current P/E
12.18x
Forward P/E
About
Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia.
Similar securities
Based on sector and market capitalization
Report issue